The peptide bond is the weakest point, so the protein will break into two pieces.... After collision with helium the peptide will break into characteristic.

Slides:



Advertisements
Similar presentations
Tandem MS (MS/MS) on the Q-ToF2
Advertisements

Genomes and Proteomes genome: complete set of genetic information in organism gene sequence contains recipe for making proteins (genotype) proteome: complete.
Signal Transduction Mechanisms Underlying Underlying Growth Control and Oncogenesis Ronit Sagi-Eisenberg Dept. of Cell and Developmental Biology Sackler.
“Signal transduction biochemistry: a field afflicted with many facts and blessed with only a few unifying principles.” R. A. Weinberg.
Clinical developmentDiscovery Typical development timeline Typically – 8 yearsTypically 7 years.
CSE182 CSE182-L12 Mass Spectrometry Peptide identification.
Fa 05CSE182 CSE182-L7 Protein sequencing and Mass Spectrometry.
Fa 05CSE182 CSE182-L8 Mass Spectrometry. Fa 05CSE182 Bio. quiz What is a gene? What is a transcript? What is translation? What are microarrays? What is.
De Novo Sequencing of MS Spectra
My contact details and information about submitting samples for MS
Proteomics Informatics (BMSC-GA 4437) Course Director David Fenyö Contact information
Evaluated Reference MS/MS Spectra Libraries Current and Future NIST Programs.
BIOL 5190/6190 Cellular & Molecular Singal Transduction
Protein sequencing and Mass Spectrometry. Sample Preparation Enzymatic Digestion (Trypsin) + Fractionation.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
OVERVIEW INTRODUCTION METHODS This approach proved successful for the isolation and quantification of the three forms of EFGR. We identified several interacting.
PROTEIN STRUCTURE NAME: ANUSHA. INTRODUCTION Frederick Sanger was awarded his first Nobel Prize for determining the amino acid sequence of insulin, the.
INF380 - Proteomics-91 INF380 – Proteomics Chapter 9 – Identification and characterization by MS/MS The MS/MS identification problem can be formulated.
Analysis of Complex Proteomic Datasets Using Scaffold Free Scaffold Viewer can be downloaded at:
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
A Phospho-Peptide Spectrum Library for Improved Targeted Assays Barbara Frewen 1, Scott Peterman 1, John Sinclair 2, Claus Jorgensen 2, Amol Prakash 1,
Mass spectroscopy – learning objectives Outline the early developments in mass spectrometry. Outline the use of mass spectrometry in the determination.
INF380 - Proteomics-101 INF380 – Proteomics Chapter 10 – Spectral Comparison Spectral comparison means that an experimental spectrum is compared to theoretical.
Temple University MASS SPECTROMETRY FURTHER INVESTIGATIONS Ilyana Mushaeva and Amber Moscato Department of Electrical and Computer Engineering Temple University.
Overview of Targeted Therapy Mechanisms November 11, 2011 Targeted Therapies and Biological Therapies SIG.
PEAKS: De Novo Sequencing using Tandem Mass Spectrometry Bin Ma Dept. of Computer Science University of Western Ontario.
CSE182 CSE182-L12 Mass Spectrometry Peptide identification.
Cell Communication Chapter Cell Communication: An Overview  Cells communicate with one another through Direct channels of communication Specific.
Src Kinase Biosensor. Outline 1.Src Kinase Introduction 2.Impacts of Src 3.Src reporter components  FPs (tECFP/EYFP)  SH2  Flexible linker  Substrate.
CSE182 CSE182-L11 Protein sequencing and Mass Spectrometry.
Russell Group, Protein Evolution _________ ____ Rob Russell Cell Networks University of Heidelberg Interactions and Modules: the how and why of molecular.
Src Kinase Activity upon substrate phosphorylation.
MECHANISM OF ACTION STUDIES IN A549 CELLS SHOW THAT MARCKS-INHIBITORY PEPTIDES (IN THIS CASE MANS PEPTIDE) BLOCKS PHOSPHORYLATION OF MARCKS IN RESPONSE.
Negative regulation of cell cycle by intracellular signals Checkpoint p53 detects DNA damage & activates p21 p21 inhibits cdk2-cyclinA Intracellular Regulation.
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
a) b) c) d) e)
B Monoisotopic mass of neutral peptide M r (calc): Fixed modifications: Carbamidomethyl Ions score: 45 † Expect: ‡ Matches (red): 18/50.
10/30/2013BCHB Edwards Project/Review BCHB Lecture 17.
Signal transduction. General scheme There are two general types of receptors: cell-surface and intracellular receptors.
EGFR exon 20 insertion mutations
Defining Epidermal Growth Factor Receptor exon 20 mutant sensitivity to tyrosine kinase inhibition Danny Rayes.
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Defining Epidermal Growth Factor Receptor exon 20 mutant sensitivity to tyrosine kinase inhibition Danny Rayes.
Sample Preparation Enzymatic Digestion (Trypsin) + Fractionation.
Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.
Macromolecules: Proteins
Cancer and Cell Communication
Laurent L'homme, PhD, David Dombrowicz, PhD 
Cell Communication (1.4) – Part 1
Cell to Cell Communication via Enzyme Linked Receptors
Proteomics Informatics David Fenyő
Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication 
Proteomic Approaches to Cancer Biomarkers
Interpretation of Mass Spectra I
Protein Synthesis Step 2: Translation
Figure 1 Specificity of the various epidermal growth factor (EGF)
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
Sequencing of targeted therapies in HER2-positive metastatic breast cancer Figure 2 from Singh et al. British Journal of Cancer (2014) 111,
Amino Acids An amino acid is any compound that contains an amino group (—NH2) and a carboxyl group (—COOH) in the same molecule.
A. Craig Lockhart, Mace L. Rothenberg, Jordan D. Berlin 
Section 8-5 “Translation”
Figure 1 from M Holderfield
Figure 1 from T Schenk et al.
Cell Communication (1.4) – Part 1
Shotgun Proteomics in Neuroscience
LEQ: Why is the eukaryotic cell cycle regulated?
Interpretation of Mass Spectra
Volume 1, Issue 3, Pages (April 2002)
Hildegard Büning, Arun Srivastava 
Presentation transcript:

The peptide bond is the weakest point, so the protein will break into two pieces.... After collision with helium the peptide will break into characteristic fragments

Example_1: Fragmentation of SLYK b-ionsy-ions SLY K Expected fragments: Total 7 peaks m/z I SLYK LYK YK K Y L S From the fragment spectra the peptide sequence can be generated

b-ionsy-ions SLY K Expected fragments: Total 7 peaks m/z I SLYK SLY SL Y K B-ions can help to identify the N-terminus of a peptide

b-ionsy-ions SLY K Expected fragments: Total 7 peaks m/z I SLYK LYK YK K m/z I SLYK SLY SL A completet spectra can be complex

How to interprete MS-spectra? 1. Try to find the C-terminal amino acid. 2. Try to find the next peak of the y-ion series in the spectra 3. Read the spectra from the tail to the head Strategy #1 Strategy #2 1.Find the peptide peak or the highest peak MW of one series. 2.Find the next peak in the series. 3.When the sequence is done, try to figure out in which way to read it. Combined Strategy 1.Find the b2/a2 pair 2.Read the b-ion series as far as you can 3.Read the y-ion series. 4.Try to match them together

Example:

Peptide C-terminal amino acid Δ113 Δ129 Δ101 Δ87 Δ233Δ128 Δ163

m/z A=71, P=97, V=99, I/L=113, N=114, D=115, M=131, H=137, F=147, K=129/147, Q=128, S=87 Y=163, E= 129 T=101 R=175 phosphorylation = +80 ICPL= +86/92 List of masses of amino acid and modifications

R I/L E T S K(12C) K (13C) Q Y Sequence: YQKSTE(I/L)(I/L)(I/L)R ICPL-

A, Overexpression and enhanced activity of the epidermal growth factor receptor (EGFR) is often observed in human cancers. EGFR is a tyrosine phosphotransferase (kinase) and abnormal EGFR-kinase activity is related to poor prognosis. Upon binding of the ligand EGFR undergoes autophosphorylation (self phosphorylation), an important step in EGF signal transduction. Figure 1 shows the fragment spectra of the peptide (PDYQQDFFPK) generated from isolated EGFR. Please confirm the predicted sequence and mark the phosphorylation site. Figure 1: Fragment spectrum. (m/z A=71, P=97, V=99, I,=113, N=114, D=115, M=131, H=137, F=147, K=129/147, Q=128, Y=163, phosphorylation = +80) B, A pharmaceutical company wants to produce inhibitors against EGFR-kinase for cancer therapy. Please explain briefly how mass spectrometry can help to identify an inhibitor compound.